The purpose of this study is to look at the effectiveness of giving cemiplimab and XL092 before and after surgery for Anaplastic Thyroid Cancer.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
United States (Nationwide)
Sid Sheth
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Thyroid and Other Gland/Endocrine)
24-3051
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
